36 C
Lucknow
Online Latest News Hindi News , Bollywood News

India’s Cumulative COVID-19 Vaccination Coverage exceeds 112.01 Cr

English News

With the administration of 57,43,840 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 112.01 Cr (1,12,01,03,225) as per provisional reports till 7 am today.  This has been achieved through 1,14,65,001 sessions.

The break-up of the cumulative figure as per the provisional report till 7 am today include:

HCWs

1st Dose 1,03,80,417
2nd Dose 93,25,756

FLWs

1st Dose 1,83,74,014
2nd Dose 1,61,64,449

Age Group 18-44 years

1st Dose 43,18,70,709
2nd Dose 16,89,98,058

Age Group 45-59 years

1st Dose 17,81,06,875
2nd Dose 10,44,39,125

Over 60 years

1st Dose 11,16,13,882
2nd Dose 7,08,29,940
Total 1,12,01,03,225

The recovery of 11,376 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,38,37,859.

Consequently, India’s recovery rate stands at 98.26%.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 140 consecutive days now.

11,271 new cases were reported in the last 24 hours.

The Active Caseload is presently at 1,35,918 is lowest in 522 days. Active cases presently constitute 0.39% of the country’s total Positive Cases, which is lowest since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of

12,55,904 tests being conducted. India has so far conducted over 62.37 Cr (62,37,51,344) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.01% remains less than 2% for the last 51 days now. The Daily Positivity rate reported to be 0.90%. The daily Positivity rate has remained below 2% for last 41 days and below 3% for 76 consecutive days now.

Related posts

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More